Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant

Orli Binyamin1 Department of Neurology, The Agnes Ginges Center of Human Neurogenetics, Hadassah University Hospital, Jerusalem, Israel

Liraz Larush2 Casali Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel

Kati Frid1 Department of Neurology, The Agnes Ginges Center of Human Neurogenetics, Hadassah University Hospital, Jerusalem, Israel

Guy Keller1 Department of Neurology, The Agnes Ginges Center of Human Neurogenetics, Hadassah University Hospital, Jerusalem, Israel

Yael Friedman-Levi1 Department of Neurology, The Agnes Ginges Center of Human Neurogenetics, Hadassah University Hospital, Jerusalem, Israel

Haim Ovadia1 Department of Neurology, The Agnes Ginges Center of Human Neurogenetics, Hadassah University Hospital, Jerusalem, Israel

Oded Abramsky1 Department of Neurology, The Agnes Ginges Center of Human Neurogenetics, Hadassah University Hospital, Jerusalem, Israel

Shlomo Magdassi2 Casali Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel

Ruth Gabizon1 Department of Neurology, The Agnes Ginges Center of Human Neurogenetics, Hadassah University Hospital, Jerusalem, IsraelCorrespondence[email protected]

show all

Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date